Clinical trial
A Study of Oral AT2101 (Afegostat Tartrate) in Treatment-naive Patients With…
NCT00446550 · Amicus Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00446550 |
|---|---|
| Title | A Study of Oral AT2101 (Afegostat Tartrate) in Treatment-naive Patients With Gaucher Disease |
| Official title | A Randomized, Open-label Study To Assess the Safety and Tolerability of AT2101 in Treatment-naive Adult Patients With Type 1 Gaucher Disease |
| Lead sponsor | Amicus Therapeutics, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Gaucher Disease, Type 1 Gaucher Disease, Type 1 |
| Intervention type | Drug |
| Interventions | afegostat tartrate |
| Enrollment | 19 |
| Start date | Jun 11, 2008 |
| Primary completion | Aug 20, 2009 |
| Completion | Aug 20, 2009 |
| First posted | Mar 13, 2007 |
| Last update posted | Aug 15, 2018 |
| Countries | Israel, South Africa, United Kingdom, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: